ANI Pharmaceuticals Inc (ANIP)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -4,314 | 8,775 | 47,242 | 54,116 | 48,956 | 45,215 | 26,326 | 3,362 | -25,728 | -54,421 | -57,042 | -62,033 | -39,793 | -15,739 | -9,375 | -5,129 | -16,016 | -21,018 | -16,492 | 4,107 |
| Total assets | US$ in thousands | 1,283,700 | 1,287,380 | 920,753 | 914,524 | 904,422 | 889,914 | 859,341 | 765,224 | 760,087 | 739,110 | 751,334 | 744,846 | 771,598 | 470,454 | 480,159 | 463,843 | 461,190 | 462,581 | 465,391 | 482,232 |
| Operating ROA | -0.34% | 0.68% | 5.13% | 5.92% | 5.41% | 5.08% | 3.06% | 0.44% | -3.38% | -7.36% | -7.59% | -8.33% | -5.16% | -3.35% | -1.95% | -1.11% | -3.47% | -4.54% | -3.54% | 0.85% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-4,314K ÷ $1,283,700K
= -0.34%
The operating return on assets (operating ROA) for ANI Pharmaceuticals Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024.
Starting from a positive 0.85% in March 2020, the operating ROA experienced a significant decline, reaching its lowest point at -8.33% in March 2022. Subsequently, there was a gradual improvement in the metric, with positive growth observed from March 2023 onwards.
The positive trend continued with increases in each subsequent quarter until December 2024, where the operating ROA stood at -0.34%. Overall, the trend indicates a recovery in the operational efficiency and profitability of ANI Pharmaceuticals Inc after facing challenges in the previous years.
Peer comparison
Dec 31, 2024